Litigation Resolved With $775M Settlement for Patients Prescribed Blood Thinner

Pharmacy Times: A settlement has been reached for litigation filed by patients with bleeding injury following the use of a prescription blood thinner.1-2

Bayer Healthcare and Janssen Pharmaceuticals Inc., the makers of the Xarelto® (rivaroxaban), have agreed to pay $775,000,000 to resolve approximately 25,000 state and federal legal claims surrounding the medication.

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending